help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berry, S. A.
Right arrow Articles by Seelig, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berry, S. A.
Right arrow Articles by Seelig, S.

Endocrinology, Vol 115, 1164-1170, Copyright © 1984 by Endocrine Society

ARTICLES

Substantial induction of a new serum protein by growth hormone: physiochemical and physiological characterization

SA Berry and S Seelig

Serum from GH-treated hypophysectomized rats was examined by two- dimensional gel electrophoresis followed by silver staining to screen a large number of serum proteins for GH responsiveness. A distinctive, highly acidic protein of 60,000 mol wt was clearly responsive to GH administration, increasing 7-fold over levels observed in hypophysectomized controls. Administration of T4, corticosterone, and 5 alpha-dihydrotestosterone failed to induce this protein; however, addition of GH to this regimen resulted in a 60-fold increase in its concentration. Examination of proteins synthesized by isolated hepatocytes in the presence of [35S]methionine showed that this protein is of hepatic origin. Physiological and physiochemical evidence suggest that this protein is unlikely to be one of the other well documented GH- responsive serum proteins: somatomedin-C, alpha 2U-globulin, or the somatomedin-binding protein. The protein demonstrates a remarkable ontogeny, increasing 135-fold over newborn levels by 35 days of age. This is qualitatively similar to changes observed in somatomedin-C, however, the quantitative change is much more striking. Examination of the protein in an altered physiological state which limits growth (uremia) reveals a 30-fold diminution of levels of the protein after 3 weeks of renal failure. In contrast, pair-fed animals demonstrated only a 2-fold decrease. This suggests that there is a profound inhibition of GH action which is not accounted for by poor nutritional intake. This protein may be useful in the investigation of the GH-hepatic axis.


This article has been cited by other articles:


Home page
 FASEB J.Home page
H. C. HATCHER, N. M. WRIGHT, J. CHAO, L. CHAO, and J.-X. MA
Kallikrein-binding protein is induced by growth hormone in the dwarf rat
FASEB J, October 1, 1999; 13(13): 1839 - 1844.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
P. L. Bergad, H.-M. Shih, H. C. Towle, S. J. Schwarzenberg, and S. A. Berry
Growth Hormone Induction of Hepatic Serine Protease Inhibitor 2.1 Transcription Is Mediated by a Stat5-related Factor Binding Synergistically to Two [IMAGE]-Activated Sites
J. Biol. Chem., October 20, 1995; 270(42): 24903 - 24910.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1984 by The Endocrine Society